Literature DB >> 23695048

Psychiatric screening for migraine patients.

O Gambini1, B Biagianti, L Grazzi, S Usai, S Scarone, G Bussone.   

Abstract

Psychiatric disorders in migraine patients have a higher prevalence than general population. The presence of psychiatric comorbidities may influence the complexity of the migraine pictures and be related to medication overuse. Severely impaired chronic migraineurs presenting with medication overuse are a challenge for headache clinics. Psychiatric comorbities, such as dependency-like behaviors, anxiety and mood symptoms, might account for headache-related disability and recurrent relapses into medication overuse after a successful detoxification. Within a sample of 63 chronic migraineurs with medication overuse and severe disability, we investigated to which extent clinical severity, affective states and attitudes about medication impact the overall functioning at time of detoxification. To unravel whether some of these factors could predict their long-term outcome, we followed and retest them 1 year after withdrawal. We hypothesized that the detoxification would have led to a partial improvement and not modified the attitudes toward medication and dependence. Detoxification improves most of the clinical and affective measures, but does not free from significant levels of pain intensity and headache-related disability. The partial benefit from detoxification, the severity bias and the maladaptive cognitive profile led us to believe that subgroups of chronic-relapsing migraineurs deserve a multidisciplinary approach that addresses not only the reduction of clinical severity but also specific cognitive and behavioral impairments.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695048     DOI: 10.1007/s10072-013-1359-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

Review 1.  What is the role of dependence-related behavior in medication-overuse headache?

Authors:  Françoise Radat; Michel Lanteri-Minet
Journal:  Headache       Date:  2010-08-27       Impact factor: 5.887

2.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

3.  Orbitofrontal dysfunction and medication overuse in patients with migraine.

Authors:  Bruno Biagianti; Licia Grazzi; Orsola Gambini; Susanna Usai; Riccardo Muffatti; Silvio Scarone; Gennaro Bussone
Journal:  Headache       Date:  2012-11-12       Impact factor: 5.887

Review 4.  Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.

Authors:  W F Stewart; R B Lipton; A J Dowson; J Sawyer
Journal:  Neurology       Date:  2001       Impact factor: 9.910

5.  Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine.

Authors:  Arnaud Fumal; Steven Laureys; Laura Di Clemente; Mélanie Boly; Valentin Bohotin; Michel Vandenheede; Gianluca Coppola; Eric Salmon; Ron Kupers; Jean Schoenen
Journal:  Brain       Date:  2005-12-05       Impact factor: 13.501

6.  Cognitive function in major depression.

Authors:  M P Austin; M Ross; C Murray; R E O'Carroll; K P Ebmeier; G M Goodwin
Journal:  J Affect Disord       Date:  1992-05       Impact factor: 4.839

7.  Frontal lobe dysfunction in patients with chronic migraine: a clinical-neuropsychological study.

Authors:  Franco Mongini; Roberto Keller; Andrea Deregibus; Erica Barbalonga; Tullia Mongini
Journal:  Psychiatry Res       Date:  2005-01-30       Impact factor: 3.222

8.  The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache.

Authors:  Christofer Lundqvist; Kjersti Aaseth; Ragnhild Berling Grande; Jūrate Saltyte Benth; Michael Bjørn Russell
Journal:  Pain       Date:  2010-01-13       Impact factor: 6.961

9.  Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.

Authors:  M E Bigal; A M Rapoport; F D Sheftell; S J Tepper; R B Lipton
Journal:  Cephalalgia       Date:  2004-06       Impact factor: 6.292

10.  Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse.

Authors:  Marian Gómez-Beldarrain; María Carrasco; Amaia Bilbao; Juan C García-Moncó
Journal:  J Headache Pain       Date:  2011-04-17       Impact factor: 7.277

View more
  2 in total

1.  Dependency-like behaviors and pain coping styles in subjects with chronic migraine and medication overuse: results from a 1-year follow-up study.

Authors:  Bruno Biagianti; Licia Grazzi; Susanna Usai; Orsola Gambini
Journal:  BMC Neurol       Date:  2014-09-19       Impact factor: 2.474

Review 2.  Risk of medication overuse headache across classes of treatments for acute migraine.

Authors:  Kristian Thorlund; Christina Sun-Edelstein; Eric Druyts; Steve Kanters; Shanil Ebrahim; Rahul Bhambri; Elodie Ramos; Edward J Mills; Michel Lanteri-Minet; Stewart Tepper
Journal:  J Headache Pain       Date:  2016-11-24       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.